United Kingdom · How much has Ellipses Pharma raised?
Ellipses Pharma has raised $136M across 9 rounds since 2019.
2019202020212022202320242025
$1.3MRound$66MRound$1.2MRound$12MRound$11MRound$1.3MRound$2.5MRound$40MRound
United Kingdom · Funded startup
Who invested in Ellipses Pharma
9 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Follow Ellipses Pharma and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$136Mraised across 9 rounds since 2019, from 9 sources
$66MRound$40MRound
- Latest round
- Round, $40MDec 2025
- Biggest round
- $66MRound · Jul 2022
- Step-upi
- 15.9×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $1.3M Mar 2019
- Biggest round
- $66M Round · Jul 2022
- Usual gap between rounds
- 7 months the median of 8
The rounds
- Dec 2025Round$40M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Feb 2025Round$2.5M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jun 2024Round$949K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Mar 2024Round$1.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Dec 2023Round$11M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- May 2023Round$12M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Dec 2022Round$1.2M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Jul 2022Round$66M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Mar 2019Round$1.3M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Ellipses Pharma filed 11 raises, $136M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Dec 2025$40MUK share allotment
- Feb 2025$2.5MUK share allotment
- Jun 2024$949KUK share allotment
- Mar 2024$1.3MUK share allotment
- Dec 2023$11MUK share allotment
- Jun 2023$2.5MUK share allotment
- May 2023$9.6MUK share allotment
- Dec 2022$1.2MUK share allotment
- Aug 2022$60MUK share allotment
- Jul 2022$6.1MUK share allotment
- Mar 2019$1.3MUK share allotment
Founders and team
From Ellipses Pharma's own website: 8 on the team.
- David CookChief Financial Officer
- Martin DoorbarChief Development Officer, Non Clinical
- Nicky Pattrick. PhDChief Business Development Officer
- Suzanne WoodChief HR Officer
- Bissan MusaNon-Executive Director
- Dr Fahad KhaterNon-Executive Director
- Luke SlatfordDirector of Operations
- Sarah JacksonGeneral Counsel and Company Secretary
Quick answers about Ellipses Pharma
When did Ellipses Pharma last raise?
Ellipses Pharma's most recent round, $40M, was in Dec 2025.
What was Ellipses Pharma's biggest round?
Ellipses Pharma's largest round on record is $66M, in Jul 2022.
Where is Ellipses Pharma based?
Ellipses Pharma is based in the United Kingdom.
Companies like Ellipses Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.